Mikrobiol. Z. 2020; 82(6):64-73.
doi: https://doi.org/10.15407/microbiolj82.06.064

The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration
of Chondroitin Sulfate and Probiotic

O.H. Korotkyi, T.V. Luhovska, T.M. Serhiychuk, K.O. Dvorshchenko,
T.M. Falalyeyeva, L.I. Ostapchenko

Taras Shevchenko National University of Kyiv
64/13 Volodymyrska Str., Kyiv, 01601, Ukraine

Osteoarthritis is a most widespread chronic degenerative joint disease that causes pain, cartilage deformation, and joint inflammation. Adverse alterations of intestinal microbiota like dysbiosis may lead to metabolic syndrome and inflammation, two important components of osteoarthritis progression. Aim. In this study we investigated the effect of chondroitin sulfate and probiotics on the gut microbiome in monoiodoacetate-induced osteoarthritis model in rats. Methods. The species and quantitative composition of feces were determined using diagnostic media with selective properties. Further identification of isolated microorganisms was carried out according to morphological, tinctorial, physiological and metabolic parameters. The results are presented in the form of lg CFU/g. Results. Induction of osteoarthritis caused significant increasing the number of opportunistic enterobacteria and lactose-negative Escherichia coli against the decreasing of lacto- and bifidobacteria that may indicate a dysbiotic condition. Coadministration of chondroitin sulfate and probiotic bacteria has led to improvement the quantitative composition of the gut microbiota in experimental animals, the numerous of Bifidobacterium, Lactobacillus were increasing against decreasing the quantitative composition of opportunistic microorganisms. Conclusions. Monoiodoacetate-induced osteoarthritis caused dysbiosis of gut in rat. We observed beneficial effect of combined administration of chondroitin sulfate and probiotics on gut microbiota composition in rats with experimental osteoarthritis. Thus, adding of supplements like probiotics to standard treatment of osteoarthritis may have potentials to prevent and treat this disease.

Keywords: gut microbiota, dysbiosis, osteoarthritis, probiotic, chondroitin sulfate.

Full text (PDF, in English)

  1. Korotkyi O, Kyriachenko Y, Kobyliak N, Falalyeyeva T, Ostapchenko L. Crosstalk between gut microbiota and osteoarthritis: A critical view. Journal of Functional Foods. 2020; 68:103904. https://doi.org/10.1016/j.jff.2020.103904
  2. Bivera E, Berenbaumb F, Valdesc AM, Carvalhod AI, et al. Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Res Rev. 2019; 55:1–8. https://doi.org/10.1016/j.arr.2019.100946
  3. Zhi YK, Sunil KL. The Human Gut Microbiome – A Potential Controller of Wellness and Disease. Front Microbiol. 2018; 9:1–23. https://doi.org/10.3389/fmicb.2018.01835
  4. Szychlinska MA, Michelino DR, Castorina A, Mobasheri A, Musumecia G. A correlation between intestinal microbiota dysbiosis and osteoarthritis. Heliyon. 2019; 5(1):1–26. https://doi.org/10.1016/j.heliyon.2019.e01134
  5. Kyriachenko Y, Falalyeyeva T, Korotkyi O, Molochek N, Kobyliak N. Crosstalk between gut microbiota and antidiabetic drug action. World J Diabetes. 2019; 10(3):154–168. https://doi.org/10.4239/wjd.v10.i3.154
  6. Collins K, Paul H, Reimer R, Seerattan R, Hart D, Herzog W. Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model. Osteoarthritis and Cartilage. 2015; 23:1989–1998. https://doi.org/10.1016/j.joca.2015.03.014
  7. Jörg J. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol. 2011; 2011:1–17. https://doi.org/10.1155/2011/969012
  8. Segarra S, Martínez-Subiela S, Cerdà-Cuéllar M, Martínez-Puig D, Muñoz-Prieto A, et al. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial. BMC Veterinary Research. 2016; 12:1–9. https://doi.org/10.1186/s12917-016-0676-x
  9. Takahashi I, Matsuzaki T, Kuroki H, Hoso M. Induction of osteoarthritis by injecting monosodium iodoacetate into the patellofemoral joint of an experimental rat model. PloS one. 2018; 13(4):1–15. https://doi.org/10.1371/journal.pone.0196625
  10. Korotkyi OH, Vovk AA, Halenova TI, Vovk TB, Dvorshchenko KO, Falalyeyeva TM, Ostapchenko LI. Cytokines profile in knee cartilage of rats during monoiodoacetate-induced osteoarthritis and administration of probiotic. Biopolym Cell. 2020; 36(1):23–35. https://doi.org/10.7124/bc.000A1E
  11. Korotkyi O, Dvorshchenko K, Vovk A, Dranitsina A, Tymoshenko M, Kot L, Ostapchenko L. Effect of probiotic composition on oxidative/antioxidant balance in blood of rats under experimental osteoarthritis. Ukr Biochem J. 2019; 91(6):49–58. https://doi.org/10.15407/ubj91.06.049
  12. Putnikov A, Holota Yu, Sergeychuk T, et al. [Quantitative and functional characteristics of rat intestinal microbiota]. Microbiology and Biotechnology. 2015; 2:89–100. Ukrainian. https://doi.org/10.18524/2307-4663.2015.2(30).48083
  13. Guzman R, Evans M, Bove S, Morenko B, Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol. 2003; 31:619–624. https://doi.org/10.1080/01926230390241800
  14. Lauder RM. Chondroitin sulphate: A complex molecule with potential impacts on a wide range of biological systems. Complementary therapies in medicine. 2009; 17(1):56–62. https://doi.org/10.1016/j.ctim.2008.08.004
  15. Hochberg MC, Martel-Pelletier J, Monfort J, Möller I, Castillo JR, et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016; 75(1):37–44. https://doi.org/10.1136/annrheumdis-2014-206792
  16. Zhang J, Zhang J, Wang R. Gutmicrobiotamodulates Drug Pharmacokinetics. Drug Metab Rev. 2018; 50:357–368. https://doi.org/10.1080/03602532.2018.1497647
  17. Webb CR, Koboziev I, Furr KL, Grisham MB. Protective and Pro-Inflammatory Roles of Intestinal Bacteria. Pathophysiology. 2016; 23(2):67–80. https://doi.org/10.1016/j.pathophys.2016.02.002
  18. Qingsen S, Yeshi Y, Liying Z, Guoyun L, Guangli Y, Xin W. Degradation of chondroitin sulfate by the gut microbiota of Chinese individuals. International Journal of Biological Macromolecules. 2016; 86:112–118. https://doi.org/10.1016/j.ijbiomac.2016.01.055
  19. Shmagel A, Demmer R, Knights D, Butler M, Langsetmo L, Nancy E, et al. The Effects of Glucosamine and Chondroitin Sulfate on Gut Microbial Composition: A Systematic Review of Evidence from Animal and Human Studies. Nutrients. 2019; 11(2):1–14. https://doi.org/10.3390/nu11020294
  20. Coulson S, Butt H, Vecchio P, Gramotnev H, Vitetta L. Green-lipped mussel extract (Perna canaliculus) and glucosamine sulphate in patients with knee osteoarthritis: therapeutic efficacy and effects on gastrointestinal microbiota profiles. Inflammopharmacology. 2013; 21:79–90. https://doi.org/10.1007/s10787-012-0146-4
  21. Shang Q, Shi J, Song G, Zhang M, Cai C, Hao J, Li G, Yu G. Structural modulation of gut microbiota by chondroitin sulfate and its oligosaccharide. Int J Biol Macromol. 2016; 89:489–498. https://doi.org/10.1016/j.ijbiomac.2016.04.091
  22. Dumais SG, Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis and Cartilage. 2008; 16(3):14–18. https://doi.org/10.1016/j.joca.2008.06.008
  23. Korotkyi O, Vovk A, Blokhina O, Dvorshchenko K, Falalyeyeva T, Abenavoli L, Ostapchenko L. Effect of Chondroitin Sulfate on Blood Serum Cytokine Profile during Carrageenan-induced Edema and Monoiodoacetate-induced Osteoarthritis in Rats. Reviews on Recent Clinical Trials. 2019; 14(1):50–55. https://doi.org/10.2174/1574887113666181102111247
  24. Korotkyi O, Vovk A, Dranitsina A, Falalyeyeva T, Dvorshchenko K, Fagoonee S, Ostapchenko L. The influence of probiotic diet and chondroitin sulfate administration on Ptgs2, Tgfb1 and Col2a1 expression in rat knee cartilage during monoiodoacetate-induced osteoarthritis. Minerva Medica. 2019; 110(5):419–424. https://doi.org/10.23736/S0026-4806.19.06063-4
  25. Liu F, Zhang N, Li Z, Wang X, Shi H, Xue C, Li RW, Tang Q. Chondroitin sulfate disaccharides modified the structure and function of the murine gut microbiome under healthy and stressed conditions. Sci Rep. 2017; 7(1):1–14. https://doi.org/10.1038/s41598-017-05860-6
  26. Qi W, Shui-Qing H, Chang-Qing L, Qin X, Qing-Ping Z. Akkermansia muciniphila May Determine Chondroitin Sulfate Ameliorating or Aggravating Osteoarthritis. Front Microbiol. 2017; 8:1–6. https://doi.org/10.3389/fmicb.2017.01955
  27. Korotkyi O, Vovk A, Galenova T, Vovk T, Dvorshchenko K, Luzza F, et al. Effect of probiotic on serum cytokines and matrix metalloproteinases profiles during monoiodoacetate-induced osteoarthritis in rats. Minerva Biotecnologica. 2019; 31(2):68–73. https://doi.org/10.23736/S1120-4826.19.02548-5
  28. Kwon JY, Lee SH, Jhun J, Choi J, Jung K, Cho KH, Kim SJ, et al. The Combination of Probiotic Complex, Rosavin, and Zinc Improves Pain and Cartilage Destruction in an Osteoarthritis Rat Model. J Med Food. 2018; 21(4):364–371. https://doi.org/10.1089/jmf.2017.4034
  29. Rios JL, Bomhof MR, Reimer RA, Hart DA, Collins KH & Herzog W. Protective effect of prebiotic and exercise intervention on knee health in a rat model of diet-induced obesity. Scientific Reports. 2018; 9:1–10. https://doi.org/10.1038/s41598-019-40601-x
  30. Schott E, Farnsworth WC, Grier A, Lillis JA, Soniwala S. Targeting the gut microbiome to treat the osteoarthritis of obesity. JCI Insight. 2018; 3(8):1–18. https://doi.org/10.1172/jci.insight.95997
  31. Sim BY, Choi HJ, Kim MG, Jeong DG, Lee DG, Yoon JM, Kang DJ, Park S, et al. Effects of IDCBT5101 in preventing and alleviating osteoarthritis symptoms in a monosodium iodoacetate-induced rat model. J Microbiol Biotechnol. 2018; 28:1199–1208. https://doi.org/10.4014/jmb.1803.03032
  32. Korotkyi O, Vovk A, Kuryk O, Dvorschenko K, Falalyeyeva T, Ostapchenko L. Co-administration of alive probiotics with chondroprotector in experimental knee osteoarthritis management. Georgian medical news. 2018; 6(279):191–196.
  33. Henrotin Y, Patrier S, Pralus A, Roche M, Nivoliez A. Protective Actions of Oral Administration of Bifidobacterium longum CBi0703 in Spontaneous Osteoarthritis in Dunkin Hartley Guinea Pig Model. Cartilage. 2019; 13:1–10. https://doi.org/10.1177/1947603519841674
  34. Sarika A, Vinod S, Rambir S, Poonam S, Poonam K, Avnish K. Lactobacillus casei reduces the Inflammatory Joint Damage Associated with Collagen-Induced Arthritis (CIA) by Reducing the Pro-Inflammatory Cytokines. J Clin Immunol. 2011; 31:147–154. https://doi.org/10.1007/s10875-010-9457-7
  35. So SJ, Song MK, Kwon HK, Lee CG, Chae CS, Sahoo A, Jash A, et al. Lactobacillus casei enhances type II collagen/glucosamine-mediated suppression of inflammatory responses in experimental osteoarthritis. Life Sci. 2011; 88:358–366. https://doi.org/10.1016/j.lfs.2010.12.013
  36. Lei M, Guo C, Wang D, Zhang C, Hua L. The effect of probiotic Lactobacillus casei Shirota on knee osteoarthritis: a randomised double-blind, placebo-controlled clinical trial. Benef Microbes. 2017; 8(5):697–703. https://doi.org/10.3920/BM2016.0207
  37. Coulson S, Vecchio P, Gramotnev H, Vitetta L. Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study. Inflammopharmacology. 2012; 20(2):71–76. https://doi.org/10.1007/s10787-012-0128-6
  38. Korotkyi O, Dvorshchenko K, Falalyeyeva T, Sulaieva O, Kobyliak N, Abenavoli L, Fagoonee S, Pellicano R, Ostapchenko L. Combined effects of probiotic and chondroprotector during osteoarthritis in rats. Panminerva Medica. 2020; 62(2):93–101. https://doi.org/10.23736/S0031-0808.20.03841-0
  39. Dranitsina AS, Dvorshchenko KO, Korotkyi OH, Vovk AA, Falalyeyeva TM, Grebinyk DM, Ostapchenko LI. Expression of Nos2 and Acan Genes in Rat Knee Articular Cartilage in Osteoarthritis. Cytol Genet. 2019; 53(6):481–488. https://doi.org/10.3103/S0095452719060021
  40. Dranitsina AS, Dvorshchenko KO, Korotkyi AG, Grebinyk DM, Ostapchenko LI. Expression of Ptgs2 and Tgfb1 Genes in Rat Cartilage Cells of the Knee under Conditions of Osteoarthritis. Cytol Genet. 2018; 52(3):192–197. https://doi.org/10.3103/S0095452718030039
  41. Vitetta L, Coulson S, Linnane AW, Butt H. The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics. Pathogens. 2013; 2:606–626. https://doi.org/10.3390/pathogens2040606
  42. Tai FD, McAlindon ME. NSAIDs and the small bowel. Current Opinion in Gastroenterology. 2018; 34(3):175–182. https://doi.org/10.1097/MOG.0000000000000427
  43. Tenti S, Giordano N, Mondanelli N, Giannotti S, Emmanuel, et al. A retrospective observational study of glucosamine sulfate in addition to conventional therapy in hand osteoarthritis patients compared to conventional treatment alone. Aging Clinical and Experimental Research. 2020; 32(6):1161–1172. https://doi.org/10.1007/s40520-019-01305-4